[1]Molecules,2019,vol.24
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
115022-95-2
53485-07-7
854813-77-7
201985-01-5
4916-20-5
4742-01-2
2106-40-3 | 1-Chloro-2,4,6-trifluorobenzene | AA002KTH | MFCD00012239
21106-04-7 | O-Cbz-l-tyrosine | AA002L35 | MFCD00056724
22911-39-3 | 4-(Nitrooxy)butan-1-ol | AA002LDL | MFCD18157664
22978-25-2 | 2-chloro-5-nitro-N-phenylbenzamide | AA002LOM | MFCD01215270
2304-98-5 | Z-Arg(no2)-oh | AA002LWB | MFCD00038092
23123-11-7 | 3-(4-Fluorophenoxy)pyrrolidine HCl | AA002M5K | MFCD09879244
23197-67-3 | 2-(4-Methoxyphenyl)-malonic acid diethyl ester | AA002MF6 | MFCD04038965
232951-83-6 | tert-Butyl 2-chloronicotinate | AA002MQ0 | MFCD18434485
234108-58-8 | tert-Butyl 4-(2-aminoethyl)-3-oxopiperazine-1-carboxylate | AA002N27 | MFCD28053710
235094-03-8 | (3S)-3-Ethylpyrrolidine hydrochloride | AA002NDS | MFCD28501900